Produktinformation
- (3β,6α,12β)-20-(β-<span class="text-smallcaps">D</smallcap>-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-<smallcap>L</smallcap>-mannopyranosyl)-β-<smallcap>D</span>-glucopyranoside
- 2-O-(6-Desoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranosid
- 2-O-(6-deoxy-α-L-mannopyranosyl)-(3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-β-D-glucopyranoside
- 2-O-(6-desoxi-α-L-manopiranosil)-(3β,6α,12β)-20-(β-D-glucopiranosiloxi)-3,12-dihidroxidamar-24-en-6-il-β-D-glucopiranosido
- 2-O-(6-desoxy-α-L-mannopyrannosyl)-(3β,6α,12β)-20-(β-D-glucopyrannosyloxy)-3,12-dihydroxydammar-24-ene-6-yl-β-D-glucopyrannoside
- Chikusetsusaponin IVc
- Ginsenoside B2
- Ginsenoside B<sub>2</sub>
- Notoginsenoside Re
- Nsc 308877
- Mehr Synonyme anzeigen
- Panaxoside Re
- Re ginsenoside
- Sanchinoside Re
- β-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, (3β,6α,12β)-20-(β-<smallcap>D</smallcap>-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-<smallcap>L</span>-mannopyranosyl)-
- 2-O-(6-Deoxy-alpha-L-mannopyranosyl)-(3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl-beta-D-glucopyranoside
- (3β,6α,12β)-20-(β-D-Glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranoside
- (3beta,6alpha,12beta)-20-(beta-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- Ginsenoside
- β-D-Glucopyranoside, (3β,6α,12β)-20-(β-D-glucopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-α-L-mannopyranosyl)-
- (3beta,6alpha,9xi,12beta,13alpha)-20-[(3xi)-beta-D-ribo-hexopyranosyloxy]-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
- 20-(hexopyranosyloxy)-3,12-dihydroxydammar-24-en-6-yl 2-O-(6-deoxyhexopyranosyl)hexopyranoside
Ginsenoside Re, a main phytosterol of Panax ginseng, inhibits Ca(2+) accumulation in mitochondria during cardiac ischemia/reperfusion, which is attributable to nitric oxide (NO)-induced Ca(2+) channel inhibition and K(+) channel activation in cardiac myocytes, acts as a specific agonist for the nongenomic pathway of sex steroid receptors, and NO released from activated eNOS underlies cardiac K(+) channel activation and protection against ischemia-reperfusion injury, G-Re also exerts antiischemic effect and induces angiogenic regeneration.[1,2]
Chemische Eigenschaften
Technische Anfrage zu: BP-BP0662 Ginsenoside Re
Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.